Zymeworks Inc.

General ticker "ZYME" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.1B (TTM average)

Zymeworks Inc. follows the US Stock Market performance with the rate: 50.1%.

Estimated limits based on current volatility of 1.7%: low 26.94$, high 27.87$

Factors to consider:

  • Total employees count: 294 as of 2022
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [16.98$, 34.54$]
  • 2026-12-31 to 2027-12-31 estimated range: [14.03$, 29.53$]

Financial Metrics affecting the ZYME estimates:

  • Negative: with PPE of -24.7 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -1.64 <= 0.07
  • Positive: Shareholder equity ratio, % of 77.48 > 64.25
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Investing cash flow per share per price, % of 1.33 > -0.65
  • Negative: negative Net income
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term ZYME quotes

Long-term ZYME plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $76.01MM $76.30MM $105.97MM
Operating Expenses $214.06MM $213.41MM $198.51MM
Operating Income $-138.05MM $-137.11MM $-92.55MM
Non-Operating Income $18.81MM $20.50MM $12.79MM
R&D Expense $143.62MM $134.62MM $137.00MM
Income(Loss) $-119.24MM $-116.61MM $-79.75MM
Taxes $-0.57MM $6.08MM $1.38MM
Profit(Loss)* $-118.67MM $-122.69MM $-81.13MM
Stockholders Equity $464.81MM $338.77MM $268.50MM
Assets $580.88MM $463.09MM $346.53MM
Operating Cash Flow $-118.30MM $-110.04MM $-33.01MM
Capital expenditure $4.08MM $3.07MM $1.52MM
Investing Cash Flow $-207.25MM $38.76MM $26.66MM
Financing Cash Flow $81.85MM $-20.45MM $-18.56MM
Earnings Per Share** $-1.72 $-1.62 $-1.08

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.